Ligand ID: FVX


Drugbank ID:
DB00176
(Fluvoxamine)



Indication:
Indicated predominantly for the management of depression and for Obsessive Compulsive Disorder (OCD) [FDA Label]. Has also been used in the management of bulimia nervosa [A250].


Get human targets for FVX in PDB (known and potential targets)

RESULTS FROM SUB-STRUCTURAL SIMILARITY SEARCHES MAPPED TO LIGAND 'FVX'

Click here for results that match SARS-Cov-2 / COVID-19 structures only
Click here for results that match SARS-related structures only


1) User may click on the DrReposER ID (the second column) to get information on the binding sites and drug molecule.
2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).
3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera through AutoDock Vina.


DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
View Interface RMSD Seq.
Identity (%)
HETATM Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AWP_A_FVXA701_1
(SODIUM-DEPENDENT
SEROTONIN
TRANSPORTER)
1q2w 3C-LIKE PROTEASE
(SARSr-CoV)
5 / 9
ASP A 153
SER A 158
SER B 123
GLY B 124
THR A 292
1.68A20.55
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
1uk3 3C-LIKE PROTEINASE
(SARSr-CoV)
5 / 12
LEU B 220
ILE B 259
ALA B 260
THR B 224
ALA B 267
1.26A21.46
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
1wnc E2 GLYCOPROTEIN
(SARSr-CoV)
6 / 12
LEU A 927
ILE A1160
ALA B 926
THR B 923
ALA C 926
THR C 923
1.69A13.79
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
1xak ORF7A ACCESSORY
PROTEIN
(SARSr-CoV)
5 / 11
ALA A  49
TYR A  60
PHE A  31
SER A  29
GLY A  27
1.63A10.00
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
1zv8 E2 GLYCOPROTEIN
(SARSr-CoV)
6 / 12
LEU C  27
ILE B  12
ALA E  26
THR E  23
ALA A  26
THR A  23
1.63A7.46
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
2acf REPLICASE
POLYPROTEIN 1AB
(SARS-COV
Tor2)
5 / 12
LEU C 235
ILE C 217
ALA C 271
ALA C 238
THR C 239
1.23A19.23
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
2amq 3C-LIKE PROTEINASE
(SARSr-CoV)
5 / 12
LEU A 220
ILE A 259
ALA A 260
THR A 224
ALA A 267
1.29A21.62
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AWP_A_FVXA701_1
(SODIUM-DEPENDENT
SEROTONIN
TRANSPORTER)
2amq 3C-LIKE PROTEINASE
(SARSr-CoV)
5 / 9
ASP B 153
SER B 158
SER A 123
GLY A 124
THR B 292
1.61A20.73
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
2beq SPIKE GLYCOPROTEIN
(SARSr-CoV)
6 / 12
LEU B 927
ILE D1161
ALA C 926
THR C 923
ALA A 926
THR A 923
1.63A5.92
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AWP_A_FVXA701_1
(SODIUM-DEPENDENT
SEROTONIN
TRANSPORTER)
2dd8 IGG HEAVY CHAIN
IGG LIGHT CHAIN
(Homo
sapiens)
5 / 9
SER L 178
SER H 179
SER H 180
GLY H 139
THR L 115
1.55A15.70
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
2dd8 SPIKE GLYCOPROTEIN
(SARSr-CoV)
5 / 11
ALA S 406
TYR S 410
PHE S 416
GLY S 400
ASP S 385
1.22A18.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
2fav REPLICASE
POLYPROTEIN 1AB
(PP1AB) (ORF1AB)
(SARSr-CoV)
5 / 12
LEU A  54
ILE A  36
ALA A  90
ALA A  57
THR A  58
1.23A19.58
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
2fe8 REPLICASE
POLYPROTEIN 1AB
(SARSr-CoV)
5 / 11
ALA C 140
TYR C 137
GLY C 101
SER C 104
GLY C 143
1.58A22.39
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
2ghv SPIKE GLYCOPROTEIN
(SARSr-CoV)
5 / 11
ALA E 406
TYR E 410
PHE E 416
GLY E 400
ASP E 385
1.27A15.38
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AWP_A_FVXA701_1
(SODIUM-DEPENDENT
SEROTONIN
TRANSPORTER)
2ghw ANTI-SCFV ANTIBODY,
80R
SPIKE GLYCOPROTEIN
(Homo
sapiens;
SARSr-CoV)
5 / 9
ASN C 479
SER D 163
PHE D 203
SER D 184
SER D 195
1.71A16.94
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
2gri NSP3
(SARSr)
5 / 11
VAL A  62
ALA A  61
PHE A  88
SER A  84
ASP A  29
1.33A14.39
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
2h85 PUTATIVE ORF1AB
POLYPROTEIN
(SARSr-CoV)
6 / 12
PHE A 329
LEU A 297
ILE A 295
ILE A 305
THR A 192
ALA A 325
1.71A21.17
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AWP_A_FVXA701_1
(SODIUM-DEPENDENT
SEROTONIN
TRANSPORTER)
2k87 NSP3 OF REPLICASE
POLYPROTEIN 1A
(SARSr)
5 / 9
ASP A  21
SER A  47
PHE A  42
GLY A  41
THR A  26
1.48A11.48
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
2ozk URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARSr-CoV)
6 / 12
PHE C 329
LEU C 297
ILE C 295
ILE C 305
THR C 321
ALA C 325
1.43A21.73
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
2pwx 3C-LIKE PROTEINASE
(SARS-COV
BJ01)
5 / 12
ALA A 193
THR A 196
GLY A 138
ALA A 173
THR A 135
1.25A21.68
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
2q6g REPLICASE
POLYPROTEIN 1AB
(SARS-COV
BJ01)
5 / 12
LEU A 220
ILE A 259
ALA A 260
THR A 224
ALA A 267
1.30A21.46
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AWP_A_FVXA701_1
(SODIUM-DEPENDENT
SEROTONIN
TRANSPORTER)
2qc2 3C-LIKE PROTEINASE
(-)
5 / 9
ASP B 153
SER B 158
SER A 123
GLY A 124
THR B 292
1.62A20.84
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
2rhb URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARSr-CoV)
6 / 12
PHE B 302
LEU B 331
ILE B 306
ALA B 234
GLY B 246
THR B 340
1.56A21.71
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AWP_A_FVXA701_1
(SODIUM-DEPENDENT
SEROTONIN
TRANSPORTER)
2rhb URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARSr-CoV)
5 / 9
ASP F 267
ILE D  42
SER F 273
GLY D  13
THR D  33
1.69A21.42
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AWP_A_FVXA701_1
(SODIUM-DEPENDENT
SEROTONIN
TRANSPORTER)
2vj1 MAIN PROTEINASE
(SARSr-CoV)
5 / 9
ASP B 153
SER B 158
SER A 123
GLY A 124
THR B 292
1.73A20.33
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
3aw0 3C-LIKE PROTEINASE
(SARSr-CoV)
5 / 12
LEU A 282
ILE A 281
ALA A 206
GLY A 258
ALA A 211
1.27A21.46
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
3bgf SPIKE PROTEIN S1
(SARSr-CoV)
5 / 11
ALA S 406
TYR S 410
PHE S 416
GLY S 400
ASP S 385
1.22A14.88
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AWP_A_FVXA701_1
(SODIUM-DEPENDENT
SEROTONIN
TRANSPORTER)
3bgf F26G19 FAB
(Mus
musculus)
5 / 9
ASN C 161
SER B 180
SER B 181
GLY B 141
THR C 114
1.19A15.50
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AWP_A_FVXA701_1
(SODIUM-DEPENDENT
SEROTONIN
TRANSPORTER)
3e91 3C-LIKE PROTEINASE
(SARSr-CoV)
5 / 9
ASP B 153
SER B 158
SER A 123
GLY A 124
THR B 292
1.60A20.70
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
3e9s NSP3
(SARSr-CoV)
5 / 11
ALA A 140
TYR A 137
GLY A 101
SER A 104
GLY A 143
1.51A22.35
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
3ea7 3C-LIKE PROTEINASE
(SARSr-CoV)
5 / 12
LEU A 220
ILE A 259
ALA A 260
THR A 224
ALA A 267
1.30A21.68
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
3f9e 3C-LIKE PROTEINASE
(SARSr-CoV)
5 / 12
ALA A 193
THR A 196
GLY A 138
ALA A 173
THR A 135
1.27A21.88
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
3f9e 3C-LIKE PROTEINASE
(SARSr-CoV)
5 / 11
VAL A 157
GLY A  11
SER A 113
GLY A 149
ASP A 155
1.44A20.67
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AWP_A_FVXA701_1
(SODIUM-DEPENDENT
SEROTONIN
TRANSPORTER)
3f9g 3C-LIKE PROTEINASE
(SARSr-CoV)
5 / 9
ASP B 153
SER B 158
SER A 123
GLY A 124
THR B 292
1.73A20.36
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
3f9h 3C-LIKE PROTEINASE
(SARSr-CoV)
5 / 11
ASP A 216
ALA B 140
GLY A 283
PHE A   3
GLY A   2
1.62A20.87
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
3i6l HLA, A-24
(Homo
sapiens)
5 / 11
ASP D 102
VAL D  28
GLY D 100
GLY D 167
ASP D  30
1.59A20.15
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AWP_A_FVXA701_1
(SODIUM-DEPENDENT
SEROTONIN
TRANSPORTER)
3m3s 3C-LIKE PROTEINASE
(SARSr-CoV)
5 / 9
ASP B 153
SER B 158
SER A 123
GLY A 124
THR B 292
1.70A20.70
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
3m3v 3C-LIKE PROTEINASE
(SARSr-CoV)
5 / 12
LEU B 220
ILE B 259
ALA B 260
THR B 224
ALA B 267
1.18A21.68
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AWP_A_FVXA701_1
(SODIUM-DEPENDENT
SEROTONIN
TRANSPORTER)
3m3v 3C-LIKE PROTEINASE
(SARSr-CoV)
5 / 9
ASP B 153
SER B 158
SER A 123
GLY A 124
THR B 292
1.55A20.84
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
3r24 2'-O-METHYL
TRANSFERASE
NSP10 AND NSP11
(SARSr-CoV)
5 / 12
ALA A 107
THR A  82
ALA A  79
GLY A  77
ALA B  71
1.30A18.22
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AWP_A_FVXA701_1
(SODIUM-DEPENDENT
SEROTONIN
TRANSPORTER)
3snd 3C-LIKE PROTEINASE
(SARSr-CoV)
5 / 9
ASP A 153
SER A 158
SER B 123
GLY B 124
THR A 292
1.64A20.70
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
4m0w REPLICASE
POLYPROTEIN 1A
(SARSr-CoV)
5 / 11
ALA A 140
TYR A 137
GLY A 101
SER A 104
GLY A 143
1.56A22.30
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
4mm3 PAPAIN-LIKE
PROTEINASE
(SARSr-CoV)
5 / 11
ALA B 140
TYR B 137
GLY B 101
SER B 104
GLY B 143
1.51A22.35
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
4rna PAPAIN-LIKE PROTEASE
(Human
betacoronavirus
2c
EMC/2012)
6 / 12
PHE A  79
LEU A 133
ILE A 130
ALA A 150
GLY A  12
ALA A 132
1.80A22.42
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
5b6o 3C-LIKE PROTEINASE
(SARSr-CoV)
5 / 12
LEU A 220
ILE A 259
ALA A 260
THR A 224
ALA A 267
1.28A21.00
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AWP_A_FVXA701_1
(SODIUM-DEPENDENT
SEROTONIN
TRANSPORTER)
5c5o 3C-LIKE PROTEINASE
(SARSr-CoV)
5 / 9
ASP B 153
SER B 158
SER A 123
GLY A 124
THR B 111
1.64A20.88
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
5e6j REPLICASE
POLYPROTEIN 1AB
(SARSr-CoV)
5 / 11
ALA D 140
TYR D 137
GLY D 101
SER D 104
GLY D 143
1.60A22.30
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
5rfc 3C-LIKE PROTEINASE
(SARS-CoV-2)
5 / 12
PHE A   3
PHE A 294
LEU A 250
ILE A 249
ALA A 206
1.39A15.37
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
5rfc 3C-LIKE PROTEINASE
(SARS-CoV-2)
5 / 12
PHE A 219
LEU A 282
ILE A 281
ALA A 206
ALA A 210
1.66A15.37
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
5tl6 REPLICASE
POLYPROTEIN 1AB
(SARSr-CoV)
5 / 11
ALA B 140
TYR B 137
GLY B 101
SER B 104
GLY B 143
1.42A22.22
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
5wrg SPIKE GLYCOPROTEIN
(SARSr-CoV)
5 / 12
PHE B 741
ILE B 724
ILE B 975
GLY A 981
THR B 980
1.25A16.36
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
5x4r S PROTEIN
(MERS-CoV)
5 / 12
ILE A 143
ILE A 300
ALA A  89
ALA A 138
GLY A 128
1.30A20.67
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
5x4r S PROTEIN
(MERS-CoV)
5 / 11
VAL A 315
TYR A  85
GLY A 115
GLY A 255
ASP A  83
1.65A20.84
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
5x4s SPIKE GLYCOPROTEIN
(SARSr-CoV)
6 / 12
PHE A 185
ALA A 250
ALA A 233
TRP A 101
GLY A 100
ALA A  90
1.69A19.08
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AWP_A_FVXA701_1
(SODIUM-DEPENDENT
SEROTONIN
TRANSPORTER)
5x58 SPIKE GLYCOPROTEIN
(SARS-COV
BJ01)
5 / 9
ASP B 518
PHE B 529
SER B 310
GLY B 311
THR B 539
1.71A18.89
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
5x59 S PROTEIN
(MERS-CoV)
5 / 12
ILE A 143
ILE A 300
ALA A  89
ALA A 138
GLY A 128
1.29A16.25
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
5x5b SPIKE GLYCOPROTEIN
(SARS-COV
BJ01)
5 / 11
VAL A 562
GLY A 534
PHE A 527
GLY A 531
ASP A 560
1.62A18.43
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
5x5c S PROTEIN
(MERS-CoV)
5 / 11
VAL B 374
ALA B 597
GLY B 615
PHE B 617
GLY B 372
1.47A17.77
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
5y3q REPLICASE
POLYPROTEIN 1A
(SARSr-CoV)
5 / 11
ALA A 140
TYR A 137
GLY A 101
SER A 104
GLY A 143
1.50A22.41
None
None
None
NA  A 405 ( 3.9A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AWP_A_FVXA701_1
(SODIUM-DEPENDENT
SEROTONIN
TRANSPORTER)
5zvm SPIKE GLYCOPROTEIN
(SARSr-CoV)
5 / 9
ILE B 955
SER C 950
PHE B 952
SER B 957
GLY B 953
1.50A9.98
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6ack SPIKE GLYCOPROTEIN
(SARSr-CoV)
5 / 12
PHE B 231
LEU B 235
ALA B 251
THR B  92
ALA B  90
1.23A16.36
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
6ack SPIKE GLYCOPROTEIN
(SARSr-CoV)
5 / 11
TYR B 660
VAL B 642
TYR B 677
SER B 659
ASP B 643
1.29A18.37
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AWP_A_FVXA701_1
(SODIUM-DEPENDENT
SEROTONIN
TRANSPORTER)
6ack SPIKE GLYCOPROTEIN
(SARSr-CoV)
5 / 9
ASN A 155
ILE A 226
SER A 111
SER A 105
GLY A 104
1.44A19.01
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
6crv SPIKE
GLYCOPROTEIN,FIBRITI
N
(SARSr-CoV)
5 / 11
VAL C 642
ALA C 676
TYR C 677
SER C 659
ASP C 643
1.62A16.94
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AWP_A_FVXA701_1
(SODIUM-DEPENDENT
SEROTONIN
TRANSPORTER)
6crv SPIKE
GLYCOPROTEIN,FIBRITI
N
(SARSr-CoV)
5 / 9
ILE C 226
PHE C 130
SER C 105
GLY C 104
THR C 160
1.76A18.72
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6crv SPIKE
GLYCOPROTEIN,FIBRITI
N
(SARSr-CoV)
5 / 12
ALA B 695
ALA C 866
GLY C 862
ALA C 874
THR C 869
1.20A17.05
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AWP_A_FVXA701_1
(SODIUM-DEPENDENT
SEROTONIN
TRANSPORTER)
6crw SPIKE
GLYCOPROTEIN,FIBRITI
N
(SARSr-CoV)
5 / 9
ASN C 692
SER C 690
PHE A 779
GLY A 781
THR A 775
1.40A18.72
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
6crw SPIKE
GLYCOPROTEIN,FIBRITI
N
(SARSr-CoV)
5 / 11
ASP B 191
ALA A 406
TYR A 410
GLY A 400
ASP A 385
1.35A17.42
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6crz SPIKE
GLYCOPROTEIN,FIBRITI
N
(SARSr-CoV)
5 / 12
LEU B1045
ILE B 800
ALA B 926
GLY B 928
THR B 706
1.08A16.67
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
6kl2 NUCLEOPROTEIN
(MERS-CoV)
5 / 11
VAL A 116
ALA A 115
GLY B  76
PHE B 113
ASP A 118
1.38A13.79
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6lxt SPIKE PROTEIN S2
(SARS-CoV-2)
6 / 12
LEU E 945
ILE E1179
ALA D 944
THR D 941
ALA F 944
THR F 941
1.61A15.03
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6lze VIRAL PROTEASE
(SARS-CoV-2)
5 / 12
LEU A 282
ILE A 281
ALA A 206
GLY A 258
ALA A 211
1.38A21.91
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6lze VIRAL PROTEASE
(SARS-CoV-2)
5 / 12
PHE A 219
LEU A 282
ILE A 281
ALA A 206
ALA A 210
1.65A21.91
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AWP_A_FVXA701_1
(SODIUM-DEPENDENT
SEROTONIN
TRANSPORTER)
6lzg SPIKE GLYCOPROTEIN
(SARS-CoV-2)
5 / 9
ASN B 388
SER B 366
PHE B 377
SER B 514
GLY B 431
1.75A17.15
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
6m0j SPIKE RECEPTOR
BINDING DOMAIN
(SARS-CoV-2)
5 / 11
ALA E 419
TYR E 423
PHE E 429
GLY E 413
ASP E 398
1.24A17.41
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6m0k VIRAL PROTEASE
(SARS-CoV-2)
5 / 12
PHE A 219
LEU A 282
ILE A 281
ALA A 206
ALA A 210
1.64A21.87
None
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6AWP_A_FVXA701_1
(SODIUM-DEPENDENT
SEROTONIN
TRANSPORTER)
6m17 SODIUM-DEPENDENT
NEUTRAL AMINO ACID
TRANSPORTER B(0)AT1
(Homo
sapiens)
5 / 9
ASN A  54
SER A 278
PHE A 283
SER A 431
GLY A 434
1.00A32.53
None
None
LEU  A 707 (-3.8A)
LEU  A 707 (-4.2A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
6m17 SODIUM-DEPENDENT
NEUTRAL AMINO ACID
TRANSPORTER B(0)AT1
(Homo
sapiens)
5 / 11
VAL C 125
TYR C 128
TYR C 129
SER C 431
ASP C 486
0.75A27.17
None
None
LEU  C 707 ( 3.9A)
LEU  C 707 (-4.2A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AWP_A_FVXA701_1
(SODIUM-DEPENDENT
SEROTONIN
TRANSPORTER)
6m1d ACE2
(Homo
sapiens)
5 / 9
ASP B 719
ASN B 718
ILE B 704
SER B 721
GLY B 726
1.12A20.99
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6m2n 3CL PROTEASE
(SARS-CoV-2)
5 / 12
LEU C 282
ILE C 281
ALA C 206
GLY C 258
ALA C 211
1.37A21.89
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6m2n 3CL PROTEASE
(SARS-CoV-2)
5 / 12
PHE B 219
LEU B 282
ILE B 281
ALA B 206
ALA B 210
1.65A21.89
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6m2n 3CL PROTEASE
(SARS-CoV-2)
5 / 12
PHE D 219
LEU D 282
ILE D 281
ALA D 206
ALA D 210
1.63A21.89
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6m2n 3CL PROTEASE
(SARS-CoV-2)
5 / 12
PHE C 219
LEU C 282
ILE C 281
ALA C 206
ALA C 210
1.62A21.89
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6m2n 3CL PROTEASE
(SARS-CoV-2)
5 / 12
PHE C   3
PHE C 294
LEU C 250
ILE C 249
ALA C 206
1.38A21.89
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6m2q 3CL PROTEASE
(SARS-CoV-2)
5 / 12
PHE A 219
LEU A 282
ILE A 281
ALA A 206
ALA A 210
1.65A21.89
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6m71 NSP8
(SARS-CoV-2)
5 / 12
PHE B 147
LEU B 153
ALA B 188
ALA B 125
ALA B 152
1.50A19.32
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6m71 NSP12
NSP8
(SARS-CoV-2)
5 / 12
PHE A 504
LEU B  98
ILE B 120
ALA A 400
GLY A 671
1.54A19.77
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6m71 NSP12
(SARS-CoV-2)
5 / 12
PHE A 165
LEU A 127
ILE A 145
ALA A 176
THR A 248
1.44A19.77
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6m71 NSP12
NSP8
(SARS-CoV-2)
5 / 12
ILE B 119
ALA B 150
ALA B 125
GLY A 385
THR B 124
1.52A19.32
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AWP_A_FVXA701_1
(SODIUM-DEPENDENT
SEROTONIN
TRANSPORTER)
6m71 NSP12
(SARS-CoV-2)
5 / 9
ASP A 135
ASN A 138
ILE A 779
SER A 784
THR A 801
1.74A20.30
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
6m71 NSP12
(SARS-CoV-2)
5 / 11
VAL A 128
GLY A  44
PHE A  45
SER A 236
ASP A 126
1.64A19.01
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6m71 NSP12
(SARS-CoV-2)
5 / 12
LEU A 891
ILE A 888
ALA A 863
ALA A 840
GLY A 839
1.55A19.77
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AWP_A_FVXA701_1
(SODIUM-DEPENDENT
SEROTONIN
TRANSPORTER)
6nb6 SPIKE GLYCOPROTEIN
(SARSr-CoV)
5 / 9
ASN B 692
SER B 690
PHE A 779
GLY A 781
THR A 775
1.55A18.84
NAG  B1326 (-3.5A)
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
6nb6 SPIKE GLYCOPROTEIN
(SARSr-CoV)
5 / 11
VAL B 642
ALA B 676
TYR B 677
SER B 659
ASP B 643
1.61A17.02
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6nb7 SPIKE GLYCOPROTEIN
(SARSr-CoV)
5 / 12
LEU A1045
ILE A 800
ALA A 926
GLY A 928
THR A 706
1.09A16.18
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AWP_A_FVXA701_1
(SODIUM-DEPENDENT
SEROTONIN
TRANSPORTER)
6nb8 S230 ANTIGEN-BINDING
(FAB) FRAGMENT,
LIGHT CHAIN
(Homo
sapiens)
5 / 9
ILE L  21
SER L  25
SER L  70
GLY L  69
THR L 107
1.65A15.36
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
6nur NSP12
NSP7
(SARSr-CoV)
5 / 11
VAL A 424
ALA A 423
TYR A 420
GLY A 432
ASP C   5
1.65A18.93
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AWP_A_FVXA701_1
(SODIUM-DEPENDENT
SEROTONIN
TRANSPORTER)
6nur NSP12
NSP8
(SARSr-CoV)
5 / 9
ASP A 269
ILE B 106
SER A 325
GLY B 113
THR B 124
1.75A20.42
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AWP_A_FVXA701_1
(SODIUM-DEPENDENT
SEROTONIN
TRANSPORTER)
6vsb SPIKE GLYCOPROTEIN
(SARS-CoV-2)
5 / 9
ASN A 710
ILE B 882
SER A 708
GLY B 885
THR B 791
1.62A18.57
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
6vsb SPIKE GLYCOPROTEIN
(SARS-CoV-2)
5 / 11
VAL B 576
GLY B 548
PHE B 541
GLY B 545
ASP B 574
1.49A19.61
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
6vw1 SARS-COV-2 CHIMERIC
RBD
(SARSr)
5 / 11
ALA F 419
TYR F 423
PHE F 429
GLY F 413
ASP F 398
1.22A15.89
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
6vw1 SARS-COV-2 CHIMERIC
RBD
(SARSr)
5 / 11
ALA E 419
TYR E 423
PHE E 429
GLY E 413
ASP E 398
1.27A15.89
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AWP_A_FVXA701_1
(SODIUM-DEPENDENT
SEROTONIN
TRANSPORTER)
6vxx SPIKE GLYCOPROTEIN
(SARS-CoV-2)
5 / 9
ASN B1098
SER B1097
PHE B1095
GLY B1093
THR B1116
1.73A18.80
NAG  B1317 (-1.9A)
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6vxx SPIKE GLYCOPROTEIN
(SARS-CoV-2)
6 / 12
LEU A 865
ILE A 870
ALA A 871
ALA A 876
GLY A 880
ALA A 783
1.75A15.85
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
6vxx SPIKE GLYCOPROTEIN
(SARS-CoV-2)
5 / 11
ALA A 419
TYR A 423
PHE A 429
GLY A 413
ASP A 398
1.30A19.14
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
6vyb SPIKE GLYCOPROTEIN
(SARS-CoV-2)
5 / 11
ALA A 419
TYR A 423
PHE A 429
GLY A 413
ASP A 398
1.30A19.22
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6vyb SPIKE GLYCOPROTEIN
(SARS-CoV-2)
6 / 12
LEU B 865
ILE B 870
ALA B 871
ALA B 876
GLY B 880
ALA B 783
1.74A15.85
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
6w37 PROTEIN 7A
(SARS-CoV-2)
5 / 11
ALA A  49
TYR A  60
PHE A  31
SER A  29
GLY A  27
1.62A6.98
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6w41 CR3022 FAB LIGHT
CHAIN
(Homo
sapiens)
5 / 12
PHE L  62
ILE L  75
ALA L  19
GLY L 101
ALA L  84
1.78A18.50
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
6w41 CR3022 FAB HEAVY
CHAIN
(Homo
sapiens)
5 / 11
TYR H  90
GLY H  65
SER H  60
GLY H  49
ASP H  86
1.57A15.78
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AWP_A_FVXA701_1
(SODIUM-DEPENDENT
SEROTONIN
TRANSPORTER)
6w41 CR3022 FAB HEAVY
CHAIN
CR3022 FAB LIGHT
CHAIN
(Homo
sapiens)
5 / 9
ASP H  54
ILE H  98
SER H  55
GLY H  97
THR L  94
1.65A15.09
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AWP_A_FVXA701_1
(SODIUM-DEPENDENT
SEROTONIN
TRANSPORTER)
6w41 CR3022 FAB HEAVY
CHAIN
CR3022 FAB LIGHT
CHAIN
(Homo
sapiens)
5 / 9
ILE H  98
SER H  55
SER H  96
GLY H  95
THR L  94
1.71A15.09
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6w41 CR3022 FAB HEAVY
CHAIN
(Homo
sapiens)
5 / 12
PHE H  29
ILE H  20
ALA H  93
GLY H  94
ALA H  78
1.71A16.19
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
6w41 SPIKE PROTEIN S1
(SARS-CoV-2)
5 / 11
ALA C 419
TYR C 423
PHE C 429
GLY C 413
ASP C 398
1.23A14.59
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AWP_A_FVXA701_1
(SODIUM-DEPENDENT
SEROTONIN
TRANSPORTER)
6w41 CR3022 FAB LIGHT
CHAIN
(Homo
sapiens)
5 / 9
ASP L  70
SER L  25
SER L  65
GLY L  64
THR L 102
1.72A14.29
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6w4h NSP10
NSP16
(SARS-CoV-2)
5 / 12
ALA A6905
THR A6880
ALA A6877
GLY A6875
ALA B4324
1.31A19.96
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 12
PHE A6985
LEU A6848
ILE A7005
ALA A7002
ALA A6966
1.42A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 12
LEU A7078
ILE A7080
ALA A6960
ALA A7056
THR A7055
1.46A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6w61 2'-O-METHYLTRANSFERA
SE
NSP10
(SARS-CoV-2)
5 / 12
ALA A6905
THR A6880
ALA A6877
GLY A6875
ALA B4324
1.30A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 11
ALA A6881
TYR A6845
GLY A6875
SER A6903
ASP A6928
1.76A
None
SAM  A7104 (-4.6A)
None
None
SAM  A7104 (-3.8A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6w63 3C-LIKE PROTEINASE
(SARS-CoV-2)
5 / 12
PHE A 219
LEU A 282
ILE A 281
ALA A 206
ALA A 210
1.64A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6w6y NSP3
(SARS-CoV-2)
5 / 12
ALA B  89
ALA B  56
GLY B  51
ALA B  60
THR B  57
1.69A17.82
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6w6y NSP3
(SARS-CoV-2)
5 / 12
ALA A  89
ALA A  56
GLY A  51
ALA A  60
THR A  57
1.70A17.82
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6w75 NSP16
(SARS-CoV-2)
5 / 12
PHE C6985
LEU C6848
ILE C7005
ALA C7002
ALA C6966
1.41A16.08
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6w75 NSP10
NSP16
(SARS-CoV-2)
5 / 12
ALA A6905
THR A6880
ALA A6877
GLY A6875
ALA B4324
1.30A16.08
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6w75 NSP10
NSP16
(SARS-CoV-2)
5 / 12
ALA C6905
THR C6880
ALA C6877
GLY C6875
ALA D4324
1.31A16.08
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6w75 NSP16
(SARS-CoV-2)
5 / 12
LEU A7078
ILE A7080
ALA A6960
ALA A7056
THR A7055
1.46A16.08
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6w75 NSP16
(SARS-CoV-2)
5 / 12
PHE A7003
LEU A6887
ALA A6881
ALA A6870
GLY A6869
1.80A16.08
None
None
None
None
SAM  A7102 ( 3.8A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6w75 NSP16
(SARS-CoV-2)
5 / 12
LEU C7078
ILE C7080
ALA C6960
ALA C7056
THR C7055
1.47A16.08
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6w75 NSP16
(SARS-CoV-2)
5 / 12
PHE A6985
LEU A6848
ILE A7005
ALA A7002
ALA A6966
1.41A16.08
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6w75 NSP10
(SARS-CoV-2)
5 / 12
LEU D4328
ILE D4334
ALA B4273
ALA B4279
ALA D4276
1.65A15.77
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)
5 / 12
PHE A 127
LEU A 152
ILE A 151
ALA A 114
THR A 168
1.61A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)
5 / 12
PHE C 127
LEU C 113
ILE C 151
ALA C 145
ALA C 139
1.53A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)
5 / 12
LEU A 117
ILE A 151
ALA A 149
THR A  90
ALA A 139
1.45A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)
5 / 12
LEU B 117
ILE B 151
ALA B 149
THR B  90
ALA B 144
1.40A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)
5 / 12
LEU A 117
ILE A 151
ALA A 149
THR A  90
ALA A 144
1.40A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)
5 / 12
LEU C 113
ILE C 151
ALA C 153
GLY C  38
THR C  90
1.58A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)
5 / 12
LEU B 117
ILE B 151
ALA B 149
THR B  90
ALA B 139
1.47A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)
5 / 12
LEU B 132
ALA B 149
ALA B 144
GLY B 142
ALA B 135
1.50A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)
5 / 12
LEU C 117
ILE C 151
ALA C 149
THR C  90
ALA C 144
1.43A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)
5 / 12
LEU A 132
ALA A 149
ALA A 144
GLY A 142
ALA A 135
1.36A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)
5 / 12
LEU B 113
ILE B 151
ALA B 153
GLY B  38
THR B  90
1.62A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)
5 / 12
LEU C 117
ILE C 151
ALA C 149
THR C  90
ALA C 139
1.49A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)
5 / 12
LEU C 291
ILE C 304
ALA D 313
THR C 263
THR C 296
1.43A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)
5 / 12
PHE F 315
LEU E 353
ILE F 320
ILE E 304
ALA E 305
1.48A
None
None
None
None
CL  E 401 ( 4.3A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)
5 / 12
PHE A 315
LEU B 353
ILE A 320
ILE B 304
ALA B 305
1.49A
None
None
None
None
CL  B 401 ( 4.3A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)
5 / 12
LEU A 291
ILE A 304
ALA B 313
THR A 263
THR A 296
1.43A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)
5 / 12
PHE C 315
LEU D 353
ILE C 320
ILE D 304
ALA D 305
1.48A
None
None
None
None
CL  D 401 ( 4.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)
5 / 12
LEU B 291
ILE B 304
ALA A 313
THR B 263
THR B 296
1.37A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)
5 / 12
PHE B 315
LEU A 353
ILE B 320
ILE A 304
ALA A 305
1.49A
None
None
None
None
CL  A 401 ( 4.3A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)
5 / 12
LEU D 291
ILE D 304
ALA C 313
THR D 263
THR D 296
1.43A
None
None
None
None
CL  D 401 ( 4.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)
5 / 12
PHE D 315
LEU C 353
ILE D 320
ILE C 304
ALA C 305
1.48A
None
None
None
None
CL  C 401 ( 4.2A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)
5 / 12
LEU F 291
ILE F 304
ALA E 313
THR F 263
THR F 296
1.40A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)
5 / 12
LEU E 291
ILE E 304
ALA F 313
THR E 263
THR E 296
1.37A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)
5 / 12
PHE E 315
LEU F 353
ILE E 320
ILE F 304
ALA F 305
1.49A
None
None
None
None
CL  F 401 ( 4.0A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 12
PHE C6985
LEU C6848
ILE C7005
ALA C7002
ALA C6966
1.41A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 12
PHE A6985
LEU A6848
ILE A7005
ALA A7002
ALA A6966
1.42A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6wjt 2'-O-METHYLTRANSFERA
SE
NSP10
(SARS-CoV-2)
5 / 12
ALA C6905
THR C6880
ALA C6877
GLY C6875
ALA D4324
1.30A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 12
LEU A7078
ILE A7080
ALA A6960
ALA A7056
THR A7055
1.43A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 12
LEU C7078
ILE C7080
ALA C6960
ALA C7056
THR C7055
1.48A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6wjt 2'-O-METHYLTRANSFERA
SE
NSP10
(SARS-CoV-2)
5 / 12
ALA A6905
THR A6880
ALA A6877
GLY A6875
ALA B4324
1.33A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6wkq NSP16
(SARS-CoV-2)
5 / 12
LEU A7078
ILE A7080
ALA A6960
ALA A7056
THR A7055
1.46A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6wkq NSP16
(SARS-CoV-2)
5 / 12
PHE C6985
LEU C6848
ILE C7005
ALA C7002
ALA C6966
1.41A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6wkq NSP16
(SARS-CoV-2)
5 / 12
PHE A6985
LEU A6848
ILE A7005
ALA A7002
ALA A6966
1.42A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6wkq NSP16
(SARS-CoV-2)
5 / 12
LEU C7078
ILE C7080
ALA C6960
ALA C7056
THR C7055
1.47A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6wkq NSP10
NSP16
(SARS-CoV-2)
5 / 12
ALA C6905
THR C6880
ALA C6877
GLY C6875
ALA D4324
1.32A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6wkq NSP10
NSP16
(SARS-CoV-2)
5 / 12
ALA A6905
THR A6880
ALA A6877
GLY A6875
ALA B4324
1.33A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)
5 / 12
PHE A 330
LEU A 298
ILE A 296
THR A 326
THR A 275
1.50A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)
5 / 12
PHE B 233
PHE B 330
ILE B 306
ILE B 323
GLY B 254
1.33A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)
5 / 12
PHE A 330
LEU A 298
ILE A 296
ILE A 306
THR A 193
1.41A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)
5 / 12
PHE A 303
LEU A 332
ILE A 307
GLY A 247
THR A 341
1.53A
None
None
None
None
U5P  A 401 ( 4.7A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)
5 / 12
PHE B 330
LEU B 298
ILE B 296
THR B 326
THR B 275
1.47A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)
5 / 12
PHE A 233
PHE A 330
ILE A 306
ILE A 328
GLY A 254
1.63A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)
5 / 12
PHE B 233
PHE B 330
ILE B 306
ILE B 328
GLY B 254
1.61A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)
5 / 12
PHE B 330
LEU B 298
ILE B 296
ILE B 306
THR B 193
1.41A
None
None
None
None
EDO  B 404 (-4.8A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)
5 / 12
PHE B 303
LEU B 332
ILE B 307
GLY B 247
THR B 341
1.53A
None
None
None
None
U5P  B 401 ( 4.8A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)
5 / 11
ALA B  60
GLY B  21
PHE B   8
SER B   2
ASP B  17
1.79A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)
5 / 11
ALA A  60
GLY A  21
PHE A   8
SER A   2
ASP A  17
1.78A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)
5 / 12
PHE A 233
PHE A 330
ILE A 306
ILE A 323
GLY A 254
1.35A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6wnp 3C-LIKE PROTEINASE
(SARS-CoV-2)
5 / 12
PHE A 219
LEU A 282
ILE A 281
ALA A 206
ALA A 210
1.65A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6wq3 2'-O-METHYLTRANSFERA
SE
NSP10
(SARS-CoV-2)
5 / 12
ALA A6905
THR A6880
ALA A6877
GLY A6875
ALA B4324
1.31A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6wq3 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 12
LEU A7078
ILE A7080
ALA A6960
ALA A7056
THR A7055
1.49A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6wq3 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)
5 / 12
PHE A6985
LEU A6848
ILE A7005
ALA A7002
ALA A6966
1.43A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6wqf 3C-LIKE PROTEINASE
(SARS-CoV-2)
5 / 12
PHE A   3
PHE A 294
LEU A 250
ILE A 249
ALA A 206
1.36A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6wqf 3C-LIKE PROTEINASE
(SARS-CoV-2)
5 / 12
PHE A 219
LEU A 282
ILE A 281
ALA A 206
ALA A 210
1.66A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6wrh PEPTIDASE C16
(SARS-CoV-2)
5 / 12
LEU A 117
ILE A 151
ALA A 149
THR A  90
ALA A 139
1.44A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6wrh PEPTIDASE C16
(SARS-CoV-2)
5 / 12
LEU A 117
ILE A 151
ALA A 149
THR A  90
ALA A 144
1.54A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6wrh PEPTIDASE C16
(SARS-CoV-2)
5 / 12
LEU A 132
ALA A 149
ALA A 144
GLY A 142
ALA A 135
1.56A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6wrh PEPTIDASE C16
(SARS-CoV-2)
5 / 12
PHE A 304
ALA A 261
THR A 301
ALA A 246
GLY A 209
1.54A
None
None
GOL  A 508 (-3.8A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
6wrh PEPTIDASE C16
(SARS-CoV-2)
5 / 11
ALA A 139
TYR A 136
GLY A 100
SER A 103
GLY A 142
1.55A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6wrh PEPTIDASE C16
(SARS-CoV-2)
5 / 12
PHE A 127
LEU A 113
ILE A 151
ALA A 145
ALA A 139
1.61A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AWP_A_FVXA701_1
(SODIUM-DEPENDENT
SEROTONIN
TRANSPORTER)
6y2g REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)
5 / 9
ASP A 153
SER A 158
SER B 123
GLY B 124
THR A 292
1.73A20.58
None
None
GLY  A 401 ( 4.7A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6yb7 REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)
5 / 12
PHE A 219
LEU A 282
ILE A 281
ALA A 206
ALA A 210
1.66A15.60
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6yb7 REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)
5 / 12
PHE A   3
PHE A 294
LEU A 250
ILE A 249
ALA A 206
1.37A15.60
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AWP_A_FVXA701_1
(SODIUM-DEPENDENT
SEROTONIN
TRANSPORTER)
6yla HEAVY CHAIN
LIGHT CHAIN
(Homo
sapiens)
5 / 9
ILE B 102
SER B  56
SER B 100
GLY B  99
THR C 100
1.57A15.81
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AWP_A_FVXA701_1
(SODIUM-DEPENDENT
SEROTONIN
TRANSPORTER)
6yla HEAVY CHAIN
LIGHT CHAIN
(Homo
sapiens)
5 / 9
ILE H 102
SER H  56
SER H 100
GLY H  99
THR L 100
1.53A15.81
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
6yla SPIKE GLYCOPROTEIN
(SARS-CoV-2)
5 / 11
ALA A 419
TYR A 423
PHE A 429
GLY A 413
ASP A 398
1.28A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AWP_A_FVXA701_1
(SODIUM-DEPENDENT
SEROTONIN
TRANSPORTER)
6yla LIGHT CHAIN
(Homo
sapiens)
5 / 9
ILE C  21
SER C  25
SER C  71
GLY C  70
THR C 108
1.72A16.54
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6yla LIGHT CHAIN
(Homo
sapiens)
5 / 12
LEU C  52
THR C  59
ALA C  57
GLY C  72
ALA C  40
1.54A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AWP_A_FVXA701_1
(SODIUM-DEPENDENT
SEROTONIN
TRANSPORTER)
6yla LIGHT CHAIN
SPIKE GLYCOPROTEIN
(Homo
sapiens;
SARS-CoV-2)
5 / 9
ASN A 388
ILE C  34
PHE A 515
SER A 383
GLY A 381
1.74A16.70
None
None
None
DMS  A 905 (-3.9A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6yla LIGHT CHAIN
(Homo
sapiens)
5 / 12
LEU L  52
THR L  59
ALA L  57
GLY L  72
ALA L  40
1.63A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
6yla SPIKE GLYCOPROTEIN
(SARS-CoV-2)
5 / 11
ALA E 419
TYR E 423
PHE E 429
GLY E 413
ASP E 398
1.28A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AWP_A_FVXA701_1
(SODIUM-DEPENDENT
SEROTONIN
TRANSPORTER)
6yla HEAVY CHAIN
LIGHT CHAIN
(Homo
sapiens)
5 / 9
ASP B  55
ILE B 102
SER B  56
GLY B 101
THR C 100
1.52A15.81
MLI  B 302 ( 4.1A)
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
6yla HEAVY CHAIN
SPIKE GLYCOPROTEIN
(Homo
sapiens;
SARS-CoV-2)
5 / 11
VAL E 407
TYR E 508
GLY H  54
SER E 375
ASP E 405
1.56A
None
DMS  E 902 (-4.0A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
6yla HEAVY CHAIN
(Homo
sapiens)
5 / 11
TYR H  94
GLY H  66
SER H  61
GLY H  49
ASP H  90
1.53A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AWP_A_FVXA701_1
(SODIUM-DEPENDENT
SEROTONIN
TRANSPORTER)
6yla HEAVY CHAIN
LIGHT CHAIN
(Homo
sapiens)
5 / 9
ASP H  55
ILE H 102
SER H  56
GLY H 101
THR L 100
1.52A15.81
MLI  E 908 (-3.9A)
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AWP_A_FVXA701_1
(SODIUM-DEPENDENT
SEROTONIN
TRANSPORTER)
6yla HEAVY CHAIN
LIGHT CHAIN
(Homo
sapiens)
5 / 9
ILE H 102
SER H  56
SER H 100
GLY H  98
THR L 100
1.78A15.81
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
6yla HEAVY CHAIN
(Homo
sapiens)
5 / 11
TYR B  94
GLY B  66
SER B  61
GLY B  49
ASP B  90
1.54A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
6ym0 HEAVY CHAIN
(Homo
sapiens)
5 / 11
TYR H  94
GLY H  66
SER H  61
GLY H  49
ASP H  90
1.55A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6ym0 LIGHT CHAIN
(Homo
sapiens)
5 / 12
LEU L  52
THR L  59
ALA L  57
GLY L  72
ALA L  40
1.55A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6ym0 HEAVY CHAIN
(Homo
sapiens)
5 / 12
PHE H  29
ILE H  20
ALA H  97
GLY H  98
ALA H  79
1.66A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AWP_A_FVXA701_1
(SODIUM-DEPENDENT
SEROTONIN
TRANSPORTER)
6ym0 HEAVY CHAIN
LIGHT CHAIN
(Homo
sapiens)
5 / 9
ILE H 102
SER H  56
SER H 100
GLY H  99
THR L 100
1.60A15.94
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
6ym0 SPIKE GLYCOPROTEIN
(SARS-CoV-2)
5 / 11
ALA E 419
TYR E 423
PHE E 429
GLY E 413
ASP E 398
1.26A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
6ym0 HEAVY CHAIN
SPIKE GLYCOPROTEIN
(Homo
sapiens;
SARS-CoV-2)
5 / 11
VAL E 407
TYR E 508
GLY H  54
SER E 375
ASP E 405
1.58A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AWP_A_FVXA701_1
(SODIUM-DEPENDENT
SEROTONIN
TRANSPORTER)
6ym0 HEAVY CHAIN
LIGHT CHAIN
(Homo
sapiens)
5 / 9
ASP H  55
ILE H 102
SER H  56
GLY H 101
THR L 100
1.56A15.94
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6ynq REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)
5 / 12
PHE A 219
LEU A 282
ILE A 281
ALA A 206
ALA A 210
1.66A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6yor IGG L CHAIN
(Homo
sapiens)
5 / 12
LEU L  52
THR L  59
ALA L  57
GLY L  72
ALA L  40
1.62A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AWP_A_FVXA701_1
(SODIUM-DEPENDENT
SEROTONIN
TRANSPORTER)
6yor IGG H CHAIN
IGG L CHAIN
(Homo
sapiens)
5 / 9
ILE B 102
SER B  56
SER B 100
GLY B  98
THR C 100
1.77A15.81
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AWP_A_FVXA701_1
(SODIUM-DEPENDENT
SEROTONIN
TRANSPORTER)
6yor IGG H CHAIN
IGG L CHAIN
(Homo
sapiens)
5 / 9
ILE H 102
SER H  56
SER H 100
GLY H  99
THR L 100
1.54A15.81
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
6yor IGG H CHAIN
(Homo
sapiens)
5 / 11
TYR B  94
GLY B  66
SER B  61
GLY B  49
ASP B  90
1.53A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
6yor IGG H CHAIN
SPIKE GLYCOPROTEIN
(Homo
sapiens;
SARS-CoV-2)
5 / 11
VAL E 407
TYR E 508
GLY H  54
SER E 375
ASP E 405
1.55A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AWP_A_FVXA701_1
(SODIUM-DEPENDENT
SEROTONIN
TRANSPORTER)
6yor IGG H CHAIN
IGG L CHAIN
(Homo
sapiens)
5 / 9
ASP H  55
ILE H 102
SER H  56
GLY H 101
THR L 100
1.52A15.81
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
6yor SPIKE GLYCOPROTEIN
(SARS-CoV-2)
5 / 11
ALA A 419
TYR A 423
PHE A 429
GLY A 413
ASP A 398
1.28A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AWP_A_FVXA701_1
(SODIUM-DEPENDENT
SEROTONIN
TRANSPORTER)
6yor IGG H CHAIN
IGG L CHAIN
(Homo
sapiens)
5 / 9
ILE H 102
SER H  56
SER H 100
GLY H  98
THR L 100
1.78A15.81
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
6yor IGG H CHAIN
(Homo
sapiens)
5 / 11
TYR H  94
GLY H  66
SER H  61
GLY H  49
ASP H  90
1.52A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
6yor IGG H CHAIN
SPIKE GLYCOPROTEIN
(Homo
sapiens;
SARS-CoV-2)
5 / 11
VAL A 407
TYR A 508
GLY B  54
SER A 375
ASP A 405
1.55A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AWP_A_FVXA701_1
(SODIUM-DEPENDENT
SEROTONIN
TRANSPORTER)
6yor IGG H CHAIN
IGG L CHAIN
(Homo
sapiens)
5 / 9
ASP B  55
ILE B 102
SER B  56
GLY B 101
THR C 100
1.52A15.81
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
6yor SPIKE GLYCOPROTEIN
(SARS-CoV-2)
5 / 11
ALA E 419
TYR E 423
PHE E 429
GLY E 413
ASP E 398
1.27A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
6yor IGG L CHAIN
(Homo
sapiens)
5 / 12
LEU C  52
THR C  59
ALA C  57
GLY C  72
ALA C  40
1.62A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AWP_A_FVXA701_1
(SODIUM-DEPENDENT
SEROTONIN
TRANSPORTER)
6yor IGG H CHAIN
IGG L CHAIN
(Homo
sapiens)
5 / 9
ILE B 102
SER B  56
SER B 100
GLY B  99
THR C 100
1.53A15.81
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
7bqy MAIN PROTEASE
(SARS-CoV-2)
5 / 12
PHE A 219
LEU A 282
ILE A 281
ALA A 206
ALA A 210
1.64A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
7bqy MAIN PROTEASE
(SARS-CoV-2)
5 / 12
PHE A   3
PHE A 294
LEU A 250
ILE A 249
ALA A 206
1.34A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
7btf NSP12
(SARS-CoV-2)
5 / 12
LEU A 891
ILE A 888
ALA A 863
ALA A 840
GLY A 839
1.55A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
7btf NSP12
NSP8
(SARS-CoV-2)
5 / 12
LEU A 270
ALA B 150
ALA B 125
GLY A 385
THR B 123
1.54A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
7btf NSP12
(SARS-CoV-2)
5 / 11
ASP A 717
VAL A 776
ALA A 771
TYR A 770
GLY A 774
1.64A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
7btf NSP12
(SARS-CoV-2)
5 / 11
TYR A 887
ASP A 418
VAL A 844
GLY A 841
ASP A 846
1.65A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
7btf NSP12
(SARS-CoV-2)
5 / 11
VAL A 128
GLY A  44
PHE A  45
SER A 236
ASP A 126
1.68A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
7btf NSP12
NSP8
(SARS-CoV-2)
5 / 12
ILE B 119
ALA B 150
ALA B 125
GLY A 385
THR B 124
1.52A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
7btf NSP12
NSP8
(SARS-CoV-2)
5 / 12
PHE A 396
LEU A 270
ALA B 125
GLY A 385
THR B 123
1.60A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
7btf NSP12
(SARS-CoV-2)
5 / 12
PHE A 165
LEU A 127
ILE A 145
ALA A 176
THR A 248
1.44A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
7buy VIRUS MAIN PROTEASE
(SARS-CoV-2)
5 / 12
PHE A 219
LEU A 282
ILE A 281
ALA A 206
ALA A 210
1.64A
None
DMS  A 404 (-4.9A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
7bv1 NSP12
(SARS-CoV-2)
5 / 12
LEU A 891
ILE A 888
ALA A 863
ALA A 840
GLY A 839
1.49A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
7bv1 NSP12
NSP7
(SARS-CoV-2)
5 / 11
ASP C   5
VAL A 424
ALA A 423
TYR A 420
SER C   4
1.64A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
7bv1 NSP12
(SARS-CoV-2)
5 / 11
VAL A 128
GLY A  44
PHE A  45
SER A 236
ASP A 126
1.79A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
7bv1 NSP12
NSP7
(SARS-CoV-2)
5 / 11
VAL A 424
ALA A 423
TYR A 420
GLY A 432
ASP C   5
1.59A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
7bv1 NSP12
(SARS-CoV-2)
5 / 12
PHE A 165
LEU A 127
ILE A 145
ALA A 176
THR A 248
1.44A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
7bv1 NSP12
(SARS-CoV-2)
5 / 11
ASP A 717
VAL A 776
ALA A 771
TYR A 770
GLY A 774
1.59A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
7bv1 NSP12
(SARS-CoV-2)
5 / 12
PHE A 480
LEU A 575
ILE A 579
ALA A 634
THR A 686
1.61A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
7bv1 NSP12
NSP8
(SARS-CoV-2)
5 / 12
ILE B 119
ALA B 150
ALA B 125
GLY A 385
THR B 124
1.55A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
7bv2 NSP12
(SARS-CoV-2)
5 / 11
TYR A 887
ASP A 418
VAL A 848
GLY A 841
ASP A 851
1.69A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
7bv2 NSP12
(SARS-CoV-2)
5 / 12
ILE A 450
ALA A 558
GLY A 559
ALA A 449
THR A 556
1.64A
None
None
U  T  10 ( 3.5A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
7bv2 NSP12
(SARS-CoV-2)
5 / 12
PHE A 165
LEU A 127
ILE A 145
ALA A 176
THR A 248
1.47A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
7bv2 NSP12
NSP8
(SARS-CoV-2)
5 / 12
LEU A 270
ALA B 150
ALA B 125
GLY A 385
THR B 123
1.57A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
7bv2 NSP12
(SARS-CoV-2)
5 / 12
LEU A 638
ALA A 685
THR A 687
GLY A 679
ALA A 634
1.66A
None
A  T  11 ( 4.7A)
F86  P 102 (-3.6A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
7bv2 NSP12
NSP8
(SARS-CoV-2)
5 / 12
ILE B 119
ALA B 150
ALA B 125
GLY A 385
THR B 124
1.53A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AWP_A_FVXA701_1
(SODIUM-DEPENDENT
SEROTONIN
TRANSPORTER)
7bv2 NSP12
(SARS-CoV-2)
5 / 9
ASP A 135
ASN A 138
ILE A 779
SER A 784
THR A 801
1.61A19.42
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6AWP_A_FVXA701_1
(SODIUM-DEPENDENT
SEROTONIN
TRANSPORTER)
7bv2 NSP12
NSP8
(SARS-CoV-2)
5 / 9
ILE B 119
SER A 397
SER A 325
GLY A 327
THR B 123
1.72A17.43
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
7bv2 NSP12
NSP7
(SARS-CoV-2)
5 / 11
VAL A 424
ALA A 423
TYR A 420
GLY A 432
ASP C   5
1.60A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ENH_A_FVXA602_1
(CHOLESTEROL
24-HYDROXYLASE)
7bv2 NSP12
(SARS-CoV-2)
5 / 12
PHE A 480
LEU A 575
ILE A 579
ALA A 634
THR A 686
1.61A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MM9_A_FVXA603_1
(TRANSPORTER)
7bv2 NSP12
(SARS-CoV-2)
5 / 11
VAL A 128
GLY A  44
PHE A  45
SER A 236
ASP A 126
1.76A
None